Sleep Apnea and Blood Sugar Control in Adults With Type 1 Diabetes
Tests CPAP breathing treatment in adults with type 1 diabetes and sleep apnea.
Key facts
- Who runs it
- University of Chicago
- Where
- Chicago, United StatesSee the site
- Trial code
- Registry title
- Type 1 Diabetes and Obstructive Sleep Apnea
- Status
- Recruiting
- People taking part
- 40 people, planned
- Started
- 10 Nov 2025
- Expected to end
- 31 Aug 2029
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Continuous positive airway pressure (CPAP)
- Record updated
- 20 January 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 18 to 50 with type 1 diabetes who use an insulin pump and a CGM device, and who have obstructive sleep apnea (OSA) shown by a home sleep test.
- Age
- 18 to 50 years
- Sex
- Men and women can both join.
- Disease stage
- Type 1 diabetes with a GMI (glucose management indicator) between 5.5 and 8.5%, with hemoglobin in the normal range at screening. Obstructive sleep apnea shown by a home sleep apnea test.
- Earlier treatment
- Must be on insulin pump therapy and use a CGM device. Cannot join if already using CPAP regularly as the guidelines say.
- Biomarker or test result
- GMI between 5.5 and 8.5% and hemoglobin in the normal range at screening. Sleep apnea confirmed by a home sleep apnea test.
Main reasons for not taking part
- Regular CPAP use as the guidelines say, or need for oxygen or advanced airway pressure during sleep
- Severe low blood sugar in the past 3 months, or not feeling low blood sugar coming on
- Proliferative retinopathy, kidney transplant, or serum creatinine over 1.5 mg/dL (133 µmol/L)
- Heart attack-type event (acute coronary syndrome) or stroke in the past 6 months, or severe high blood pressure
- Pregnant, trying to get pregnant or nursing
The registry criteria, word for word
Show all 22 criteriaShow less
Who can take part
- Age: 18 to 50 years old
- Type 1 Diabetes on insulin pump therapy and using a CGM device with an GMI (glucose management indicator) between 5.5 and 8.5% with hemoglobin in the normal range at screening
- OSA by home sleep apnea test
Who cannot take part
- Recent major surgery
- Subjects will also be excluded if taking medications that can confound metabolic assessments including systemic glucocorticoids, antipsychotics, thiazide diuretics, beta-blockers, daily use of aminophylline or theophylline, or use of any immunosuppressant
- Smoking, alcohol or illegal drug abuse
- Acute coronary syndrome or stroke past 6 months
- Severe hypertension (blood pressure>180/105 mmHg)
- Any other significant health condition: unstable angina, heart failure requiring hospitalization in the past 6 months, significant heart block or arrhythmias, NYHA Class>2, pulmonary disease with dependence on oxygen or daily use of bronchodilators, active or chronic infection, thyroid disease and other endocrine disorders (e.g. Cushing syndrome, acromegaly)
- Major psychiatric disorder
- ≥1 trip to emergency room for poor glucose management in the past 6 months
- Liver transaminases >2 times upper limit of normal,
- Renal transplantation or serum creatinine >1.5 mg/dL
- Anemia (hemoglobin <13.0g/dL in men or <11.6g/dL in women)
- Regular and adherent CPAP use per clinical guidelines
- Requiring oxygen or advanced positive airway pressure modalities during sleep
- Having a 'fall-asleep' or 'near miss' accident in the past 6-months
- Shift work
- Severe hypoglycemia (≥1 episode in the past 3 months or diagnosis of hypoglycemic unawareness)
- Proliferative retinopathy
- Fasting triglycerides >400mg/dL,
- Currently pregnant or trying to get pregnant or nursing
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 50 years old?
Where in United States
- University of ChicagoChicago, United StatesContact: Becky TuckerTaking people
About the trial
What the trial wants to find out
The purpose of the study is to investigate the role of sleep apnea in glycemic dysregulation in adults with Type 1 diabetes.
The 2 groups in the trial
- UntreatedNo study treatment, for comparison
No treatment for OSA
- Treated: Continuous positive airway pressure (CPAP) treatmentExisting treatment, for comparison
Treatment for OSA by CPAP
Treatment: Continuous positive airway pressure (CPAP)
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Obstructive Sleep Apnea and Glycemic Dysregulation in Adults With Type 1 Diabetes
- Plain-language title
- Sleep Apnea and Blood Sugar Control in Adults With Type 1 DiabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06915831, who can take part
- Record updated
- 20 January 2026